Abstract 1933: Improved DAMP assays for the in vitro assessment of immunogenic cell death
Abstract The extracellular levels of damage-associated molecular patterns (DAMPs) released during immunogenic cell death (ICD) are positively correlated with the magnitude and efficacy of the resulting in vivo immune response. Therefore, extracellular ATP (eATP) and high mobility group box 1 (HMGB1)...
Saved in:
Published in | Cancer research (Chicago, Ill.) Vol. 81; no. 13_Supplement; p. 1933 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
01.07.2021
|
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
The extracellular levels of damage-associated molecular patterns (DAMPs) released during immunogenic cell death (ICD) are positively correlated with the magnitude and efficacy of the resulting in vivo immune response. Therefore, extracellular ATP (eATP) and high mobility group box 1 (HMGB1) have been identified as key biomarkers for their predictive capacity during in vitro ICD screening activities. Current methods for identifying eATP and HMGB1 inducers are laborious, costly, and hampered by poor throughput. To overcome these challenges, we developed easy-to-use, homogeneous, bioluminescent assays that measure dose-dependent release of these immunostimulatory agents directly in cell culture. The eATP assay utilizes an optimized ATP detection chemistry that can be employed directly to assess live-cell kinetic responses for up to 24 h, with even longer exposures supported by a staggered reagent addition approach. The HMGB1 assay measures the protein's concentration at exposure endpoint in the same sample well using complementary luciferase fragment-labelled monoclonal antibodies. We tested the utility of the assays using U20S, Jurkat and U937 cells dosed with serial dilutions of known ICD inducers (doxorubicin, idarubicin, mitoxantrone, and bortezomib). The resulting data suggest the potency of eATP and HMGB1 release is dependent upon cell model and agent but can be reproducibly and robustly measured in 96 and 384 well environments. Further, the eATP assay produced remarkable early dose-dependent response resolution whereas the HMGB1 data provided a confirmatory post-mortem ICD parameter. This new ICD biomarker detection workflow may help to efficiently define and rank-order the capacity of new chemical entities to induce apoptosis and immunogenic cell death.
Citation Format: Andrew L. Niles, Kevin R. Kupcho, Dan F. Lazar, James J. Cali. Improved DAMP assays for the in vitro assessment of immunogenic cell death [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 1933. |
---|---|
AbstractList | Abstract
The extracellular levels of damage-associated molecular patterns (DAMPs) released during immunogenic cell death (ICD) are positively correlated with the magnitude and efficacy of the resulting in vivo immune response. Therefore, extracellular ATP (eATP) and high mobility group box 1 (HMGB1) have been identified as key biomarkers for their predictive capacity during in vitro ICD screening activities. Current methods for identifying eATP and HMGB1 inducers are laborious, costly, and hampered by poor throughput. To overcome these challenges, we developed easy-to-use, homogeneous, bioluminescent assays that measure dose-dependent release of these immunostimulatory agents directly in cell culture. The eATP assay utilizes an optimized ATP detection chemistry that can be employed directly to assess live-cell kinetic responses for up to 24 h, with even longer exposures supported by a staggered reagent addition approach. The HMGB1 assay measures the protein's concentration at exposure endpoint in the same sample well using complementary luciferase fragment-labelled monoclonal antibodies. We tested the utility of the assays using U20S, Jurkat and U937 cells dosed with serial dilutions of known ICD inducers (doxorubicin, idarubicin, mitoxantrone, and bortezomib). The resulting data suggest the potency of eATP and HMGB1 release is dependent upon cell model and agent but can be reproducibly and robustly measured in 96 and 384 well environments. Further, the eATP assay produced remarkable early dose-dependent response resolution whereas the HMGB1 data provided a confirmatory post-mortem ICD parameter. This new ICD biomarker detection workflow may help to efficiently define and rank-order the capacity of new chemical entities to induce apoptosis and immunogenic cell death.
Citation Format: Andrew L. Niles, Kevin R. Kupcho, Dan F. Lazar, James J. Cali. Improved DAMP assays for the in vitro assessment of immunogenic cell death [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 1933. |
Author | Niles, Andrew L. Cali, James J. Kupcho, Kevin R. Lazar, Dan F. |
Author_xml | – sequence: 1 givenname: Andrew L. surname: Niles fullname: Niles, Andrew L. – sequence: 2 givenname: Kevin R. surname: Kupcho fullname: Kupcho, Kevin R. – sequence: 3 givenname: Dan F. surname: Lazar fullname: Lazar, Dan F. – sequence: 4 givenname: James J. surname: Cali fullname: Cali, James J. |
BookMark | eNqdj81KAzEUhS-lQqfqIwj3BaYmMxM6uhv8QRcFF266Cun0jo1MkpIbC317DZY-QFeHc-CD78xh6oMngDspFlKq9l6qui2XTaMW3aoSlSzlQ11PoDjvUyiEEG2pmmU1gznz919VUqgC1t2GUzR9wgw94rvbx3CgLT53qw80zObIOISIaUdoPR5siiHvxOzIJwwDWud-fPgib3vsaRxxSybtbuBqMCPT7SmvQb2-fD69lX0MzJEGvY_WmXjUUuj8Q2dfnX31_w-dlepLuV8pr1KX |
ContentType | Journal Article |
DBID | AAYXX CITATION |
DOI | 10.1158/1538-7445.AM2021-1933 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1538-7445 |
EndPage | 1933 |
ExternalDocumentID | 10_1158_1538_7445_AM2021_1933 |
GroupedDBID | --- -ET 18M 29B 2WC 34G 39C 476 53G 5GY 5RE 5VS 6J9 AAYXX ABOCM ACGFO ACIWK ACPRK ACSVP ADBBV ADCOW ADNWM AENEX AFHIN AFOSN AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CITATION CS3 DIK DU5 EBS EJD F5P FRP GX1 IH2 KQ8 L7B LSO OK1 P0W P2P PQQKQ RCR RHF RHI RNS SJN TR2 W2D W8F WH7 WOQ YKV YZZ |
ID | FETCH-crossref_primary_10_1158_1538_7445_AM2021_19333 |
ISSN | 0008-5472 |
IngestDate | Thu Sep 26 17:14:46 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 13_Supplement |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-crossref_primary_10_1158_1538_7445_AM2021_19333 |
ParticipantIDs | crossref_primary_10_1158_1538_7445_AM2021_1933 |
PublicationCentury | 2000 |
PublicationDate | 2021-07-01 |
PublicationDateYYYYMMDD | 2021-07-01 |
PublicationDate_xml | – month: 07 year: 2021 text: 2021-07-01 day: 01 |
PublicationDecade | 2020 |
PublicationTitle | Cancer research (Chicago, Ill.) |
PublicationYear | 2021 |
SSID | ssj0005105 |
Score | 4.8289757 |
Snippet | Abstract
The extracellular levels of damage-associated molecular patterns (DAMPs) released during immunogenic cell death (ICD) are positively correlated with... |
SourceID | crossref |
SourceType | Aggregation Database |
StartPage | 1933 |
Title | Abstract 1933: Improved DAMP assays for the in vitro assessment of immunogenic cell death |
Volume | 81 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEF5qBfEiPvHNHryFRNO8Wm-ltWhti0iFegp5YqCkpaYF-7v8gc7sJptFi1gvIdmSyTbzMTsz-WaWkCsLdFoLwHML_RtTNQPbV_3QCFS9HoWOF5mxY2Nxcn9g37-Y3ZE1qlQ-JdbSPPO1YLmyruQ_WoUx0CtWya6hWSEUBuAc9AtH0DAc_6Tjpo-JiiCDmN4wMLbnKQLwIdvN_pMCfrH38S6IhEmqLJJsNsHxvBsnaxiBFSITeEYSKJjGV0L0CmWntYXImCl5X6A39uGXMziYhRmPNSmfMEjyXbQ5VVLpaeXXoinYWl4MtIDJPItfet6S87wBg0pHDGPdmGDyKl1NzlDUdMFmLa1uXbVMvkWPFpWG1jF5K8nCEtd1GXGGyzY2LRlA3MTiG5WW6-Ly51JgYXmDeI7W7LO5lbfLrbe_LYmCqMhCJKvuohgXxbhcjItiNshmzWlYSCRtPzyWxKKcOFv867xuDMRcr5yN5BFJrs1wl-zkMQltcoDtkUqU7pOtfs66OCCvBc4oCrqlBcooooxylFFAGQWU0SSlDGW0RBmdxFRCGUWUUYayQ2J17oate7WYmjvl3U_cX1-JcUSq6SSNjgmNg4ahRwZ2RzLMUG9AKOc56AzZTgyW3z4h2nqyT9e94Yxsl3A8J9VsNo8uwIXM_EumsS-rIWgv |
link.rule.ids | 315,786,790,27955,27956 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Abstract+1933%3A+Improved+DAMP+assays+for+the+in+vitro+assessment+of+immunogenic+cell+death&rft.jtitle=Cancer+research+%28Chicago%2C+Ill.%29&rft.au=Niles%2C+Andrew+L.&rft.au=Kupcho%2C+Kevin+R.&rft.au=Lazar%2C+Dan+F.&rft.au=Cali%2C+James+J.&rft.date=2021-07-01&rft.issn=0008-5472&rft.eissn=1538-7445&rft.volume=81&rft.issue=13_Supplement&rft.spage=1933&rft.epage=1933&rft_id=info:doi/10.1158%2F1538-7445.AM2021-1933&rft.externalDBID=n%2Fa&rft.externalDocID=10_1158_1538_7445_AM2021_1933 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-5472&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-5472&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-5472&client=summon |